FEATURES
Our annual round up of the UK’s largest income stocks in which we examine how safe their dividend payments are
Private Investors Diary – Golden period
Our private investor diarist John Rosier reflects on his portfolio’s performance in June
From regulators to manufacturers and insurers to scientists, the pharma industry is changing. Companies that don’t innovate are going to get left behind. Megan Boxall investigates.
SEVEN DAYS
Our take on the biggest business stories of the past week
NEWS
IHT overhaul brings benefits and threats
PageGroup hit by global uncertainty
Menzies profits to miss expectations
News Spotlight – UK commercial property deals slump
Economic Outlook – The end of austerity, Next week’s economics
COMMENT
The Editor – Simple reform casts a dark shadow
Mr Bearbull – The weighting game
Simon Thompson – Mercia aims to double AUM to £1bn within three years, Investment company watch
Chris Dillow – Rate cut danger, On opportunity cost
Phil Oakley – Why understanding operational gearing is key to successful investing
The Trader – Do you like your commodities hard or soft?
MONEY
Portfolio Clinic – How can I achieve my target income?
TIPS
De La Rue a prisoner of the past
Eckoh capitalising on US opportunity
Get steady income and growth with First State Global Listed Infrastructure
Tips Updates
FUNDS
Hargreaves drops Lindsell Train from favourites list
The Interview – Aiming for UK growth
The Interview – Getting the right blend for attractive income
SHARES
Taking Stock – Bovis has its work cut out
Stock Screens – Eight Zulu small-caps for cheap growth
Sectors – Emperor’s new clothes
Results
DIRECTORS DEALINGS
Aston Martin non-exec in £29.5m sale